Results 251 to 260 of about 258,084 (317)

Glucocorticoid reduction after starting crinecerfont in adult patients with classic CAH: practical perspectives.

open access: yesJ Clin Endocrinol Metab
Hamidi O   +7 more
europepmc   +1 more source

Systemic Glucocorticoid Immunosuppression and Survival Among Immune Checkpoint Inhibitor Recipients.

open access: yesJAMA Netw Open
Wan G   +17 more
europepmc   +1 more source

Glucocorticoids

Best Practice & Research Clinical Rheumatology, 2011
Glucocorticoids remain part of the treatment strategy in many rheumatic diseases, because of their anti-inflammatory and immunosuppressive actions. Unfortunately, their clinically desired effects are linked to adverse effects, especially at higher dosages and longer duration of treatment.
Cornelia M, Spies   +4 more
openaire   +4 more sources

Glucocorticoids

2016
The most effective anti-inflammatory drugs used to treat patients with airways disease are topical glucocorticosteroids (GCs). These act on virtually all cells within the airway to suppress airway inflammation or prevent the recruitment of inflammatory cells into the airway.
Adcock, IM, Mumby, S
openaire   +3 more sources

Glucocorticoids and the Osteoclast

Annals of the New York Academy of Sciences, 2007
Abstract:  Glucocorticoid (GC)‐induced bone loss is the most common cause of secondary osteoporosis but its pathogenesis is controversial. GCs clearly suppress bone formation in vivo but the means by which they impact osteoblasts is unclear. Because bone remodeling is characterized by tethering of the activities of the two cells, the osteoclast is a ...
Hyun-Ju, Kim   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy